This comprehensive analysis of MUC4 and ADAM12 may help in the development of specific isoforms of these genes as prognostic biomarkers for CRC and contribute to the knowledge needed for the application of 3PM in this malignancy. The gene discussed is MUC4; the disease is colorectal carcinoma.